1-9 of 9
Ilan Shapira
Close
Sort by
Journal Articles

Phase II Study of Danazol with Plasma Exchange and Corticosteroids for the Treatment of Thrombotic Thrombocytopenic Purpura

Vamsee Torri, Mark Friedman, Ilan Shapira, Amit A. Patel, Joseph Yoe, Vijay P. Shah, Tahir Mirzoyev, Maria Machuca, Mala Varma
Journal: Blood
Blood (2023) 142 (Supplement 1): 4007.
https://doi.org/10.1182/blood-2023-178552
Published: 2023
Journal Articles

A 2 Year of Review of HIT Evaluations at an Urban Medical Center with an Aim Towards Quality Improvement and the Development of Practical Testing Strategies

Stephen Zachary Peeke, MD, Ilan Shapira, MD, Ismini Kourouni, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2322.
https://doi.org/10.1182/blood.V130.Suppl_1.2322.2322
Published: 2017
Journal Articles

Safety and Efficacy of Thrombopoietin Receptor Agonists in Patients with Previously Treated Chronic Immune Thrombocytopenia: A Systematic Review and Meta-Analysis

Yuji Yamada, MD, Takeo Fujii, MD, Caroline Cromwell, MD, Ilan Shapira, MD
Journal: Blood
Blood (2016) 128 (22): 4925.
https://doi.org/10.1182/blood.V128.22.4925.4925
Published: 2016
Journal Articles

Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial

Alexey V Danilov, MD PhD, Hongli Li, PhD, Oliver W. Press, Ilan Shapira, MD, Lode J. Swinnen, MBChB, Ariela Noy, MD, Erin Reid, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 1498.
https://doi.org/10.1182/blood.V126.23.1498.1498
Published: 2015
Journal Articles

Anti-Rh(D) Utilization Prior To and Following The FDA Mandate For Hemoglobinuria Screening 03/11/10

Mala Varma, MD, Hrvoje Melinscak, MD, Ilan Shapira, MD, Gabriel Sara, MD, Michael L. Grossbard, MD
Journal: Blood
Blood (2013) 122 (21): 4761.
https://doi.org/10.1182/blood.V122.21.4761.4761
Published: 2013
Journal Articles

Combination of Anti-Rh(D) and Danazol in Patients with Immune Thrombocytopenia

Mala Varma, MD, Ilan Shapira, MD, Ibrahim Nakhoul, MD, Jonah Shulman, MD, David Lucido, PhD, Peter Kozuch, MD, Bruce Culliney, MD, Tahir Mirzoyev, Maria Machuca, Michael L. Grossbard, MD
Journal: Blood
Blood (2012) 120 (21): 3343.
https://doi.org/10.1182/blood.V120.21.3343.3343
Published: 2012
Journal Articles

Comparison of Lengths of Stay for Inpatients with Immune Thrombocytopenia Treated with Anti-Rh(D), Intravenous Immunoglobulin, and Steroids

Hrvoje Melinscak, MD, Ilan Shapira, MD, Mala Varma, MD
Journal: Blood
Blood (2012) 120 (21): 4646.
https://doi.org/10.1182/blood.V120.21.4646.4646
Published: 2012
Journal Articles

Distinct Clinical Characteristics of Myelodysplastic Syndrome in Human Immunodeficiency Virus-Infected Patients,

Koichi Takahashi, MD, Mariko Yabe, MD, Ilan Shapira, MD, Mala Verma, MD
Journal: Blood
Blood (2011) 118 (21): 3821.
https://doi.org/10.1182/blood.V118.21.3821.3821
Published: 2011
Journal Articles

Phase II Study To Determine If Danazol Is an Anti-D Sparing Agent When Used in Combination with Anti-D for the Treatment of Immune Thrombocytopenic Purpura.

Ibrahim N. Nakhoul, MD, Ilan Shapira, MD, May Abdo-Matkiwsky, MD, Peter Kozuch, MD, Etta Frankel, MD, Sree Bhavani Chalasani, MD, Takhir Mirzoyev, Margaret Dietrich, Peter Homel, PhD, Michael L. Grossbard, MD, Mala Varma, MD
Journal: Blood
Blood (2006) 108 (11): 3983.
https://doi.org/10.1182/blood.V108.11.3983.3983
Published: 2006